Patient Navigators Boost Colon Screens in Urban ... ( Personal interventions cut no-show ra...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Patient Navigators Boost Colon Screens in Urban Minorities

Date:4/4/2008

Personal interventions cut no-show rates 30%, study finds

FRIDAY, April 4 (HealthDay News) -- Two new studies make the case that more personal guidance and encouragement will help increase the numbers of low-income and minority patients getting recommended screening for colorectal cancer.

The studies, published in current issue of Clinical Gastroenterology and Hepatology, found problems with large "safety net" health-care systems serving urban populations and hope for patient intervention programs featuring "navigators" that guide patients through preparation for the procedure and encourage their attendance.

Colon cancer, when detected early, is one of the most treatable of all cancers, with a five-year survival rate of 90 percent. However, diagnosis in the most advanced stage of the disease causes that survival rate to drop only 10 percent. The American Gastroenterological Association Institute estimates 148,800 people will be diagnosed with colorectal cancer in 2008, and almost 50,000 will die from the preventable disease.

In the first study, a research team studied six months of endoscopy laboratory scheduling and procedure logs from Denver Health Medical Center. They found 41.7 percent of the 817 people scheduled for outpatient colonoscopies failed to show. Of those who did make their appointments, 30.2 percent did not prepare their bowel properly to take the examination.

According to the Denver study, such safety net systems traditionally have a large proportion of low-income and minority patients, and their colonoscopy no-show rates are "very high." The researchers said the rate of colonoscopy non-attendance at Denver Health is comparable to similar institutions in the United States but much greater than the no-show rate at non-safety-net systems.

"Because the rationale and required steps for completing colonoscopy are complex, individual intervention with patient navigators -- no
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Healthcare providers who discuss intimate piercings earn patients trust
2. Anemia Triples Risk of Local Recurrence in Breast Cancer Patients
3. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
4. Better care for dementia patients through new funding
5. Patient charter ensures that reports on physicians are meaningful, reliable and fair
6. Antipsychotic Drugs of Little Benefit to Alzheimers Patients
7. Mayo Clinic Identifies Infection Risks for Patients with Inflammatory Bowel Disease
8. Lack of patient-provider discussion contributes to disparities in use of breast reconstruction
9. Patient charter ensures that reports on physicians are meaningful, reliable, and fair
10. URAC Announces Support for Principles of Disclosure Projects Patient Charter
11. AHIP Endorses Patient Charter to Guide Physician Performance Measurement, Reporting

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Pitt study suggests craving hinders comprehension without your realizing it 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 3 Health News:Lilly Announces the First 300-unit Vial of Insulin 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5 Health News:Pitt study suggests craving hinders comprehension without you realizing it 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3

[0] Pitt study suggests craving hinders comprehension without your realizing it [0] Lilly Announces the First 300-unit Vial of Insulin [0] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management [0] Pitt study suggests craving hinders comprehension without you realizing it [1] Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange

Julie L. Novak Named Executive Director of Michigan State Medical Society Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 National Health Care Coalition Commends New Congress' Focus on Fighting Chronic Disease in House Stimulus Package Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009 Optelec and ShopLowVision.com Bring Life Back Into Focus at ATIA 2009 Orlando Patients' Bath Basins Increase Risk for Hospital-Acquired Infections

Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7 Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2 Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6 President Obama Misleads on Abortion Funding in Health Care Reform 54931 1 President Obama Misleads on Abortion Funding in Health Care Reform 54931 2 Kaiser Workers Launch Statewide Pickets 54929 1

[0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors [0] Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology [0] Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting

American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks Savient Provides Update on Pegloticase BLA

Medicine Products:

Nucleus Chopper - P. Koch Magstim 200 Disposable Laser Fiber (For 12 Watt Laser)Single Use, 20 Gauge Illumination Probe

Patient Navigators Boost Colon Screens in Urban ...( Personal interventions cut no-show ra...),Health